Recombinant API production

Customer: Novo Nordisk A/S

The challenge:
We were one of four companies assigned to build a complete facility for recombinant API production for Novo Nordisk A/S, factor VII

Our contribution:
We supplied nine complete, fully automated process modules from basic design (process, mechanics and automation) to validation/qualification (DQ, IQ andOQ).
Automation system for all process modules based on Emerson delta V, structured according to S88 standard.

Result:
Facility completed within 18 months.